8. Conn D, Gibson M, McCabe D. CCSMH guidelines update—The assessment and
treatment of mental health issues in longterm care homes (focus on mood and behaviour …

Neurocognitive disorders (NCDs) represent a growing epidemic in the modern world,
concomitant with increasing life expectancy. NCDs represent the newer term replacing …

Dementia affects approximately 5% of people over the age of 65. While cognitive impairment
is central to the dementia concept, non-cognitive symptoms invariably occur at some point in …

Dementias, renamed neurocognitive disorders (NCDs) in the DSM-5, are defined by
acquired decline in cognitive and functional abilities. DSM-5 now also includes mild NCD …

Background: Medications are frequently prescribed for neuropsychiatric symptoms (NPS)
associated with dementia, although information on the efficacy and safety of medications for …

Recent advances in the management of neuropsychiatric sympto... : Current Opinion in
Psychiatry Recent advances in the management of neuropsychiatric symptoms in dementia …

Purpose Neuropsychiatric symptoms are universal across all stages and types of dementia
and can cause significant challenges for patients and caregivers. While there are currently …

Background Recent reports documenting limited evidence supporting the use of
pharmacological interventions for neuropsychiatric symptoms (NPS) and increased risk of …

Nonpharmacological interventions, sometimes referred to as psychosocial interventions, are
generally recommended as the first-line treatments for the management of neuropsychiatric …

Noncognitive neuropsychiatric symptoms (NPS) of dementia (aggression, agitation,
depression, anxiety, delusions, hallucinations, apathy, disinhibition) affect individuals with …